Screen-detected breast cancers have a lower mitotic activity index

por Groenendijk, R P R, Bult, P, Tewarie, L, Peer, P G M, Sluis, R F van der, Ruers, T J M, Wobbes, T
Publicado 2000

Improved survival for sequentially as opposed to concurrently delivered neoadjuvant chemotherapy in non-metastatic breast cancer

por Vriens, B. E. P. J., Vriens, I. J. H., Aarts, M. J. B., van Gastel, S. M., van den Berkmortel, F. W. P. J., Smilde, T. J., van Warmerdam, L. J. C., van Spronsen, D. J., Peer, P. G. M., de Boer, M., Tjan-Heijnen, V. C. G.
Publicado 2017

Prognosis of metastatic breast cancer: are there differences between patients with de novo and recurrent metastatic breast cancer?

por Lobbezoo, D J A, van Kampen, R J W, Voogd, A C, Dercksen, M W, van den Berkmortel, F, Smilde, T J, van de Wouw, A J, Peters, F P J, van Riel, J M G H, Peters, N A J B, de Boer, M, Peer, P G M, Tjan-Heijnen, V C G
Publicado 2015